BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25465164)

  • 1. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
    Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
    Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
    Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoid nephrosis in childhood].
    Niaudet P
    Rev Prat; 2003 Nov; 53(18):2027-32. PubMed ID: 15008217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K; Fujimoto S; Sato Y; Kitamura K
    Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kimura disease: a case report and review of the Chinese literature.
    Wang DY; Mao JH; Zhang Y; Gu WZ; Zhao SA; Chen YF; Liu AM
    Nephron Clin Pract; 2009; 111(1):c55-61. PubMed ID: 19052471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the biopsied nephrotic syndrome for 20 years in the Cadiz Bay Area: histological correspondence, renal prognosis and clinical prognostic factors].
    Quirós PL; Ceballos M; Remón C; Lozano A; del Castillo R; Aznar E; Pérez Pérez-Ruilópez MA; Rivero M; Fernández Ruiz E
    Nefrologia; 2005; 25(2):147-54. PubMed ID: 15912651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO; Gbadegesin RA; Adeyemo AA; Akang EE; Arowolo FA; Abiola OA; Osinusi K
    West Afr J Med; 1999; 18(3):203-6. PubMed ID: 10593158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term follow-up study of children with minimal change nephrotic syndrome].
    Takeichi S; Tazawa M; Morooka M; Minowa S; Yasaki T
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):155-60. PubMed ID: 9134833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal change nephrotic syndrome in adults].
    Galicia Basart M; Vallés Prats M; Ferrer Prevosti E; Piera Robert L
    Med Clin (Barc); 1989 Feb; 92(7):250-3. PubMed ID: 2716406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of heavy proteinuria in patients under 2 years of age.
    Chang JW; Lin CY
    Pediatr Nephrol; 2003 Oct; 18(10):1044-8. PubMed ID: 12898378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A; Sabry S; Emil E; El-Refaey M
    J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcome of Adult Onset Idiopathic Minimal Change Disease.
    Colattur SN; Korbet SM
    Saudi J Kidney Dis Transpl; 2000; 11(3):334-44. PubMed ID: 18209325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.